Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-20-000071
Filing Date
2020-12-07
Accepted
2020-12-07 18:21:46
Documents
1
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160738329299398.html 4  
1 FORM 4 wf-form4_160738329299398.xml 4 6997
  Complete submission text file 0001439222-20-000071.txt   8441
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Biller Jonathan (Reporting) CIK: 0001744749 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 201373825